ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 682

$1.84M Total Retail Price of All Prescriptions

Rank: 16 out of 682

762 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 762 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

34% of this provider’s 762 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 24,775 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,604 799 S3 1 1
OMEPRAZOLE 1,342 939 2 5
LISINOPRIL 1,041 690 3 2
GABAPENTIN 1,004 577 4 9
FUROSEMIDE 967 677 5 7
MELOXICAM 900 613 6 27
SIMVASTATIN 734 506 7 4
LEVOTHYROXINE SODIUM 663 472 8 3
METFORMIN HCL 623 431 9 8
POTASSIUM CHLORIDE 619 462 10 14
WARFARIN SODIUM 569 493 11 13
NEXIUM 529 271 12 19
AZITHROMYCIN 518 283 13 39
METOPROLOL TARTRATE 459 362 14 10
SERTRALINE HCL 454 393 15 24
TAMSULOSIN HCL 426 341 16 33
LEVOFLOXACIN 408 267 17 70
ATENOLOL 403 276 18 18
ZOLPIDEM TARTRATE 402 247 19 21
MIRTAZAPINE 396 296 20 52
AMLODIPINE BESYLATE 392 248 21 6
CITALOPRAM HBR 381 205 22 17
PROMETHAZINE HCL 367 162 R 23 54
ROPINIROLE HCL 356 254 24 71
PREDNISONE 345 280 25 40
CLOPIDOGREL 342 265 26 25
SUCRALFATE 337 217 27 160
TRAZODONE HCL 307 183 28 38
HYDROCHLOROTHIAZIDE 305 189 29 12
CIPROFLOXACIN HCL 291 198 30 58
PLAVIX 283 226 31 35
ATORVASTATIN CALCIUM 279 183 32 11
AMITRIPTYLINE HCL 275 154 R 33 50
TRAMADOL HCL 271 158 34 26
ETODOLAC 270 195 35 244
RANITIDINE HCL 212 151 36 28
ALLOPURINOL 211 155 37 32
SINGULAIR 211 137 37 63
GLIPIZIDE 211 142 37 61
PRAVASTATIN SODIUM 210 158 40 15
SULFAMETHOXAZOLE-TRIMETHOPRIM 205 116 41 103
DIGOXIN 199 160 42 46
NAMENDA 197 197 43 41
METOPROLOL SUCCINATE 196 157 44 16
HYDRALAZINE HCL 193 108 45 74
DILTIAZEM 24HR CD 190 154 46 123
LYRICA 188 103 47 78
SPIRONOLACTONE 188 147 47 64
PANTOPRAZOLE SODIUM 182 146 49 29
DOXEPIN HCL 181 73 50 205
TOPIRAMATE 180 62 51 150
CYMBALTA 176 114 52 51
RISPERIDONE 167 107 53 82
MEGESTROL ACETATE 166 134 R 54 165
FLUTICASONE PROPIONATE 165 85 55 36
POLYETHYLENE GLYCOL 3350 159 132 56 44
TRIAMCINOLONE ACETONIDE 158 102 57 149
AMOXICILLIN 158 107 57 113
DONEPEZIL HCL 155 155 59 30
ISOSORBIDE MONONITRATE ER 152 117 60 31
BUMETANIDE 151 109 61 115
MONTELUKAST SODIUM 150 88 62 112
CELEBREX 143 112 63 80
ACETAMINOPHEN-CODEINE 143 98 S3 63 126
CARVEDILOL 142 97 65 23
DIOVAN 142 96 65 42
EXELON 140 140 67 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 103 67 34
METHOCARBAMOL 138 50 R 69 163
LOSARTAN POTASSIUM 138 114 69 20
LANTUS 136 72 71 55
OXYCODONE HCL-ACETAMINOPHEN 135 60 S2 72 98
ZIPRASIDONE HCL 132 132 73 316
ENDOCET 131 72 S2 74 88
SYNTHROID 130 118 75 59
PAROXETINE HCL 129 89 76 53
CYCLOBENZAPRINE HCL 125 37 R 77 65
VENLAFAXINE HCL ER 124 59 78 119
FENTANYL 122 75 S2 79 86
NAPROXEN 118 51 80 97
GLYBURIDE 117 89 R 81 72
PHENYTOIN SODIUM EXTENDED 111 42 82 140
FLUOXETINE HCL 109 41 83 60
HYDROXYZINE HCL 108 43 R 84 187
CRESTOR 108 81 84 22
PROPRANOLOL HCL 107 58 86 141
CEPHALEXIN 105 73 87 128
PROAIR HFA 104 36 88 45
IBUPROFEN 103 68 89 79
LANSOPRAZOLE 101 53 90 85
FAMOTIDINE 100 76 91 99
FINASTERIDE 99 90 92 131
TIZANIDINE HCL 99 32 92 83
METOCLOPRAMIDE HCL 97 66 94 111
INSULIN SYRINGE 96 61 95 75
JANUVIA 93 65 96 62
METHYLPREDNISOLONE 90 62 97 127
DOXAZOSIN MESYLATE 87 71 98 96
LOSARTAN-HYDROCHLOROTHIAZIDE 87 56 98 56
MECLIZINE HCL 85 67 100 124
KLOR-CON M20 85 63 100 67
DIOVAN HCT 85 69 100 109
VENLAFAXINE HCL 84 13 103 225
NIFEDIPINE ER 84 84 103 144
BYSTOLIC 83 69 105 118
DIVALPROEX SODIUM 83 59 105 84
GLIMEPIRIDE 82 80 107 43
SPIRIVA 81 53 108 49
NOVOLIN 70-30 81 45 108 189
NYSTATIN-TRIAMCINOLONE 80 63 110 332
PRIMIDONE 79 50 111 228
DEXILANT 79 40 111 201
NITROGLYCERIN PATCH 79 60 111 176
KLOR-CON 10 79 62 111 148
NITROSTAT 78 28 115 161
LAMOTRIGINE 78 18 115 210
MORPHINE SULFATE 77 20 S2 117 326
DILTIAZEM ER 76 58 118 136
QUETIAPINE FUMARATE 72 48 119 87
METOLAZONE 70 42 120 229
AMIODARONE HCL 69 69 121 170
ONDANSETRON HCL 68 37 122 195
BUSPIRONE HCL 67 23 123 102
BACLOFEN 66 15 124 130
ESCITALOPRAM OXALATE 66 42 124 73
MORPHINE SULFATE ER 65 47 S2 126 143
FLUCONAZOLE 62 19 127 154
CARISOPRODOL 62 0 R 127 146
ABILIFY 62 43 127 179
ALPRAZOLAM 61 48 130 90
METHYLPHENIDATE HCL 60 45 131 439
ONGLYZA 60 60 131 219
INDOMETHACIN 60 58 R 131 290
DIPHENOXYLATE-ATROPINE 59 38 134 278
METRONIDAZOLE 58 29 135 254
AMLODIPINE BESYLATE-BENAZEPRIL 58 51 135 77
ESTRADIOL 58 11 R 135 152
NITROFURANTOIN 58 45 135 233
LIPITOR 57 41 139 92
GEODON 57 57 139 447
VENTOLIN HFA 57 41 139 101
OXYBUTYNIN CHLORIDE 56 30 142 173
NYSTATIN 55 32 143 95
NEOMYCIN-POLYMYXIN-HC 54 32 144 453
PRAMIPEXOLE DIHYDROCHLORIDE 53 33 145 190
OXYCODONE-ACETAMINOPHEN 53 26 S2 145 120
LEVETIRACETAM 52 29 147 125
RANEXA 51 46 148 223
FLOVENT HFA 51 32 148 293
CARAFATE 50 50 150 375
OLANZAPINE 50 30 150 168
LACTULOSE 50 34 150 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.